Intravenous and Intrapulmonary Administration of Honey Solution to Healthy Sheep: Effects on Blood Sugar, Renal and Liver Function Tests, Bone Marrow Function, Lipid Profile, and Carbon Tetrachloride-Induced Liver Injury

Journal of Medicinal Food

Volumn 6, Issue 3, 2003, Pages 231-247

  Al Waili, Noori S ^a,b  

^a Medical Research Laboratories   (United Arab Emirates)

^b Dubai Specialized Medical Center   (United Arab Emirates)

Author keywords

Blood sugar; Carbon tetrachloride; Dextrose; Honey; Intrapulmonary; Intravenous; Lipid profile; Renal hepatic

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; LIPID; LIVER PROTECTIVE AGENT; NATURAL PRODUCT; PLASMA PROTEIN; TRIACYLGLYCEROL; UREA; WATER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNCTION TEST; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HONEY; HYPERGLYCEMIA; INHALATION; KIDNEY FUNCTION TEST; LEUKOCYTE COUNT; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; LIVER INJURY; LIVER PROTECTION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHEEP; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ANIMALIA; OVIS ARIES;

EID: 0345708283     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/10966200360716652     Document Type: Article

References (103)

1. Oryan A, Zaker R: Effects of topical application of honey on coetaneous wound healing in rabbits. Zentralb Veterinarmed [A] 1998;45:181-188.
2. Bergman A, Yanai J, Weiss J, Bell D, David P: Acceleration of wound healing by topical application of honey. An animal model. Am J Surg 1983;145:374-376.
3. Subrahmanyam M: Topical application of honey in treatment of burns. Br J Surg 1991;78:497-498.
4. Tuck K, Hayball P: Major phenolic compounds in olive oil. J Nutr Biochem 2002;13:636-644.
5. Wahdan A: Causes of antimicrobial activity of honey. Infection 1998;26:26-31.
6. Frankel S: Antioxidant capacity and correlated characteristic of 14 unifloral honeys. J Apic Res 1998;37:347-363.
7. Elbagoury F, Rasmy S: Antibacterial action of natural honey on anaerobic bacteroides. Egypt Dent J 1993;39:381-386.
8. Obi L, Ugoji O, Edun A, Lawal F: The antibacterial effect of honey on diarrhoea causing bacterial agents isolated in Lagos, Nigeria. Afr J Med Sci 1994;23:257-260.
9. Efem E: Clinical observations on the wound healing properties of honey. Br J Surg 1988;75:679-681.
10. Al-Waili N, Jafari S, Ali A: Effects of natural honey on acute bacterial conjunctivitis due to Staphylococcus aureus. FASEB J 2001;15:A561.
11. Al-Waili N, Jafari S: Effects of honey and cloves extract on bacterial conjunctivitis due to Pseudomonas aeruginosa: compared with antibiotics. FASEB J 2001;15:A586.
12. Al-Waili N, Al-Alak J, Haq A, Shabani M, Akmal M: Effects of honey on gram positive and gram negative bacterial growth in vitro. FASEB J 2001;15;A586.
13. Zeina B, Othman O, Al-Assad S: Effect of honey versus thyme on rubella virus survival in vitro. J Altern Complement Med 1996;2:345-348.
14. Zeina B, Zohra BI, Al-Assad S: The effects of honey on Leishmania parasites: an in vitro study. Trop Doct 1997;27:36-38.
15. Keast-Butler J: Honey for necrotic malignant breast ulcers. Lancet 1980;2:809.
16. Gribel V, Pashinskii G: The antitumor properties of honey. Vopr Onkol 1990;36:704-709.
17. Khaled M, Elawadan E: New trend in management of malignant gliomas: case report. Neurooncology J 2000;2:S51.
18. Zaghloul A, El-Shattawy H, Kassem A: Honey, a prospective antibiotic: extraction, formulation, and stability. Pharmazie 2001;56:643-647.
19. Al-Waili N, Lootah S, Shaheen W: Mixture of crude honey and olive oil in natural wax to treat chronic skin disorders. FASEB J 1999;13:A846.
20. Molan P: The role of honey in the management of wounds. J Wound Care 1999;8:415-418.
21. Al-Waili N: Effects of honey on the primary and secondary immune responses due to thymus-dependent and thymus-independent antigens. Hematol J 2001;1(Suppl 1):167.
22. Abuharfeil N, Al-Oran R, Abo-Shehada M: Effects of bee honey on the proliferative activity of human B- and T-lymphocytes and the activity of phagocytes. Food Agric Immunol 1999;11:169-177.
23. Tonks A, Cooper A, Price J, Molan P, Jones P: Stimulation of t-interferon-alpha release in monocytes by honey. Cytokines 2001;14:240-242.
24. Al-Waili N: The effects of honey feeding on WBC; hemoglobin, serum iron and differential counts: comparison with dextrose and regular diet. FASEB J 2003;17:1133.
25. Al-Waili N, Boni N: Effects of honey ingestion on nitric oxide in saliva. FASEB J 2003;17:1250.
26. Al-Waili N: Identification of nitric oxide metabolites in various honeys and effects of honey on plasma and urinary nitrite/nitrate concentration. J Med Food 2003; Accepted.
27. Kandil A, El-Banby M, Abdel-Ahed K: Healing effect of floral honey and honey from sugar-fed bees on surgical wounds. Fourth International Conference of Apiculture in Tropical Climates. Cairo: International Bee Research Association, London, 1989, pp. 46-49.
28. Kandil A, El-Banby M, Abdel-ahed K: Healing effect of true floral and false non-floral honey on medical wounds. J Drug Res 1987;17:71-75.
29. Suguna L, Chandrakasan G, Thomas J: Influence of honey on collagen metabolism during wound healing in rats. J Clin Biochem Nutr 1992;13:7-12.
30. Suguna L, Chandrakasan G, Ramamoorthy U: Influence of honey on biochemical and biophysical parameters of wounds in rats. J Clin Biochem Nutr 1993;14:91-99.
31. Al-Waili N, Lootah S: Safety and effectiveness of repeated intravenous infusion of natural honey on haematological and biochemical investigations in sheep. FASEB J 2001;15:A136.
32. Al-Waili NS: Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes levels in normal individuals. J Med Food 2003;6:135-140.
33. Al-Waili NS, Boni NS: Natural honey lowers plasma prostaglandin concentrations in normal individuals. J Med Food 2003;6:129-133.
34. Al-Waili NS, Al-Azzawi HT: The effects of prostaglandin E2 on serum iron following acute and chronic blood loss. Clin Exp Pharmacol Physiol 1985;12:443-446.
35. Al-Waili N, Al-Azzawi H, Al-Niami M: Bone marrow cellular elements and peripheral blood indices following acute hemorrhage and prostaglandin E2 treatment. Saudi Med J 1983;4: 236-242.
36. Wardlaw A, Kay A: Interrelationship between T lymphocytes and eosinophils. In: Eosinophils: Biological and Clinical Aspects. (Makino S and Fukuda T, eds.) CRC Press, Boca Raton, 1992, pp. 261-271.
37. Weller P, Rand T, Barrett T: Accessory cell function of human eosinophil. J Immunol 1993; 150:2554-2562.
38. Sitasawad S, Deshpande M: Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice. Diabetes Res Clin Pract 2001;52:77-84.
39. Tay A, Ozcelikay T, Altan V: Effects of L-arginine on blood pressure and metabolic changes in fructose-hypertensive rats. Am J Hypertens 2002; 15:72-77.
40. Bantle J, Swanson J, Thomas W, Laine D: Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 1992;15: 1468-1476.
41. Abraha A, Humphreys S, Clark M, Mathews D, Frayn K: Acute effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br J Nutr 1998;80:169-175.
42. Moore M, Cherrington A, Mann S, Davis S: Acute fructose administration decreases the glycaemic response to an oral glucose tolerance test in normal adults. J Clin Endocrinol Metab 2000; 85:4515-4519.
43. Bantle JP, Raatz SK, Thomas W, Georgopoulos A: Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 2000;72:1128-1134.
44. Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y: Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 2002;132:3379-3382.
45. Orban T, Landaker E, Ruan Z, Cordeman TP, Weitgasser R, Bonner-Weir S, Jackson RA, Patti ME: High-fructose diet preserves beta-cell mass and prevents diabetes in nonobese diabetic mice: a potential role for increased insulin receptor substrate-2 expression. Metabolism 2001;50:1369-1376.
46. Moore MC, Davis SN, Mann SL, Cherrington AD: Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care 2001;24:1882-1887.
47. Moore MC, Cherrington AD, Mann SL, Davis SN: Acute fructose administration decreases glycemic response to an oral glucose tolerance test in normal adults. J Clin Endocrinol Metab 2000;85:4515-4519.
48. Watford M: Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation. Nutr Rev 2002;60:253-257.
49. Song MK, Hwang IK, Rosenthal MJ, Harris DM, Yamaguchi DT, Yip I, Go VL: Antidiabetic actions of arachidonic acid and zinc in genetically diabetic Goto-Kakizaki rats. Metabolism 2003;52:7-12.
50. Sitasawad S, Deshpande M, Katdare M, Tirth S, Parab P: Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM). Diabetes Res Clin Pract 2001;52:72-84.
51. Cheng H, Straub SG, Sharp GW: Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, galanin, and PGE2. Am J Physiol Endocrinol Metab 2003;285: E287-E294.
52. Gonzalez-Ortiz M, Martinez-Abundis E, Balcazar-Munoz B, Robles-Cervantes J: Inhibition of cyclooxygenase-1 or -2 sensitivity in healthy subjects. Horm Metab Res 2001;33:250-253.
53. Tran P, Gleason C, Piotout V: Prostaglandin E2 mediates inhibition of insulin secretion by interleukin-1 beta. J Biol Chem 1999;274:31245-31248.
54. Al-Waili N, Al-Azzawi H: The effects of prostaglandin E2 on hyperglycemia following hemorrhage and ether anesthesia. JFac Med Bagh 1981;23:405.
55. Smukler S, Tang L, Wheeler M, Salapatek A: Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release. Diabetes 2002;51:3450-3460.
56. Alemu P, Forsyth G, Searchy G: A comparison of parameters used to assess liver damage in sheep treated with carbon tetrachloride. Can J Comp Med 1997;41:420-427.
57. Hassan AS, Garwacki S, Dutkiewicz M, Dabrowski J: The changes in bile flow and its composition in sheep following liver damage by carbon tetrachloride. Arch Vet Pol 1992;32:91-99.
58. Basnet P, Matsushige K, Hase K, Kadota S, Namba T: Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull 1996;19:1479-1484.
59. Slater T, Sawyer B: The stimulatory effects of carbon tetrachloride and other halogenoalkalines on peroxidative reaction in rat liver fraction. Biochem J 1971;123:805-814.
60. Vajdovich P, Szilagyi A, Gaal T: Evaluation of blood lipid peroxidation parameters in carbon tetrachloride (CC14) toxicity in sheep. Acta Vet Hung 1995;43:423-429.
61. Comporti M: Lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 1985;53:599-611.
62. Hernandez-Munoz R, Diaz Munoz M, Lopez V, Lopez-Barrera F, Yanez L, Vidrio S, Aranda-Frausto A, Chagoya de Sanchez V: Balance between oxidative damage and proliferative potential in an experimental rat model of CC14-induced cirrhosis: protective role of adenosine administration. Hepatology 1997;26: 1100-1110.
63. Rao VS, Figueiredo EG, Melo CL, Viana GS, Menezes DB, Matos MS, Silveira ER: Protective effect of ternatin, a flavonoid isolated from Egletes viscosa Less, in experimental liver injury. Pharmacology 1994;48:392-397.
64. Arosio B, Santambrogio D, Gagliano N, Ryan A, Biasi F, Vergani C, Annoni G: Glutathione pretreatment lessens the acute liver injury induced by carbon tetrachloride. Pharmacol Toxicol 1997;81:164-168.
65. Sodergren E, Cederberg J, Vessby B, Basu S: Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats. Eur J Nutr 2001;40:10-16.
66. Theoharides T, Alexandrakis M, Kempuraj D: Anti-inflammatory actions of flavonoids and structural requirements for new design. Int J Immunopathol Pharmacol 2001;14:119-127.
67. Sheweita S, Abd El-Gabar M, Bastawy M: Carbon tetrachloride-induced changes in the activity of phase II drug-metabolizing enzyme in the liver of male rats: role of antioxidants. Toxicology 2001;28;165:217-224.
68. 4 toxicity. Biomed Environ Sci 2002;15:1871-1895.
69. Balint GA: Possible role of endogenous prostacyclin in the maintenance of hepatic integrity in rat. Exp Toxicol Pathol 1998;50: 9-11.
70. Johnston E, Kroening C: Stimulation of prostaglandin synthesis in cultured liver cells by CC14. Hepatology 1996;24:677-684.
71. Kluba-Wojewoda U: Cytoprotective effect of prostaglandin E2 and 12 in experimental liver damage. Patol Pol 1994;45:55-62.
72. Kawada N, Mizoguchi Y, Kobayashi K, Yamamoto S, Morisawa S: Arachidonic acid metabolites in carbon tetrachloride-induced liver injury. Gastroenterol Jpn 1990;25:363-368.
73. Nagai H, Shimazawa T, Yakuo I, Aoki M, Koda A, Kasahara M: The role of thromboxane A2 [TxA2] in liver injury in mice. Prostaglandins 1989;38:439-446.
74. Grossman H, White D, Grossman L, Bhathal P: Effect of interferon gamma on intrahepatic haemodynamics of the cirrhotic rat liver. J Gastroenterol Hepatol 1998;13:1058-1060.
75. Byron A, Liberatos S, Varigos G: Interferon-gamma production in atopic dermatitis: role for prostaglandins. Int Arch Allergy Immunol 1992;99:50-55.
76. Tajima S, Nishimura N, Ito K: Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury. Immunology 1985;54:57-64.
77. Al-Waili N, Thewani A, Al-Azzawi H: The effects of PGA1 on antibody production. The World Conference on Clinical Pharmacology and Therapeutics, 1980, London, pp. 0246.
78. Morio LA, Chiu H, Sprowles KA, Zhou P, Heck DE, Gordon MK, Laskin DL: Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 2001;172: 44-51.
79. Tanaka N, Tanaka K, Nagashima Y, Kondo M, Sekihara H: Nitric oxide increases hepatic arterial blood flow in rats with carbon tetrachloride-induced acute hepatic injury. Gastroenterology 1999;117:173-180.
80. Muriel P: Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 1998;56:773-779.
81. Zhu W, Fung PC: The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CC14-induced acute liver injury of mice. Free Radic Biol Med 2000;29:870-878.
82. 4 hepatotoxicity in rats. Biochem J 1989;262:721-725.
83. Smith PL: Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery. J Control Release 1997;46:99-106.
84. Byron P: Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung. Adv Drug Deliv Rev 1990;5: 107-132.
85. Mallet J, Diot P, Lemarie E: Inhalation route for administration of systemic drugs. Rev Mal Respir 1997;14:257-267.
86. Patton JS, Bukar J, Nagarajan S: Inhaled insulin. Adv Drug Deliv Rev 1999;35:235-247.
87. Laube BL, Benedict GW, Dobs AS: The lung as alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. Chest 1998;114:1734-1739.
88. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R: Large porous particles for pulmonary drug delivery. Science 1997;276:1868-1871.
89. Cefalu W, Skyler J, Kourdes I: Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med 2001; 134:203-207.
90. Salzman R, Manson JE, Griffing GT, Kimmerle R, Ruderman N, McCall A, Stoltz El, Mullin C, Small D, Armstrong J, et al. Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes. N Engl J Med 1985;312:1078-1084.
91. Kern W, Born J, Schreiber H, Fehm HL: Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 1999;48:557-563.
92. Carlsson PO, Iwase M, Jansson L: Stimulation of intestinal glucoreceptors in rats increases pancreatic islet blood flow through vagal mechanisms. Am J Physiol 1999;276:R233-R236.
93. Lam C, van Heerden PV, Sviri S, Roberts BL, Ilett K: The effects of inhalation of a novel nitric oxide donor, DETA/NO, in a patient with severe hypoxaemia due to acute respiratory distress syndrome. Anaesth Intensive Care 2002;30:472-476.
94. Rajek A, Pemerstorefer T, Kastner J, Mares P, Grabenwoger M, Sessler D, Grubhofer G, Hiesmayr M: Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E 1 during heart transplantation. Anesth Analg 2000;90:523-530.
95. Lewis K, Cadieux A, Rae G, Gratton JP, D'Orleans-Juste P: Nitric oxide limits the eicosanoid-dependent bronchoconstriction and hypotension included by endothelin-1 in the guinea-pig. Br J Pharmacol 1999; 126:93-102.
96. Song M, Bhagat L, Singh P, Van Acker G, Steer ML, Saluja A: Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 2002;283:G1166-G1174.
97. Montuschi P, Barnes P: Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002;109:615-620.
98. Wills P, Greenstone M: Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2002;(1):CD002996.
99. Hogman M, Hageman C, Hua X: Hyperosmolar saline induces airway resistance changes and neuropeptide release: a comparison with the effect of capsaicin, potassium and histamine. Eur J Clin Invest 1999;29:264-269.
100. Chen Z: Effects of nebulized distilled water on tracheal reaction in asthmatic patients. Zhonghua Yi Xue Za Zhi 1989;69:668-670.
101. Finnerty J, Wilmot C, Holgate S: Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Evidence for predominant role of histamine. Am Rev Respir Dis 1989;140:593-597.
102. Al-Waili N: Topical application of natural honey, beeswax and olive oil mixture to treat patients with atopic dermatitis or psoriasis. Complement Ther Med 2003; In press.
103. Mendie UE, Hugbo PG, Nasipuri RN: Consequences of inadvertent microbial contamination of dextrose solutions. West Afr J Med 1996;15:190-195.